Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Cedric Rossi
  • Cedric Rossi

Luxury & Fashion NIKE Q1 FY23 results: upbeat sales outlook overshadow...

Luxury & Fashion NIKE Q1 FY23 results: upbeat sales outlook overshadowed inventory & margin concerns

Khalid Deojee
  • Khalid Deojee

GENEURO - BUY | EUR4 H1 2022 results, financed beyond the next inflect...

Company financed beyond phase 2 long-COVID readout in Q2 2023 Re-iterate BUY and look forward for long-COVID readout and potential partnerships as catalysts

Gregory Ramirez
  • Gregory Ramirez

ATOS: The Board rejects a non-binding unsolicited offer for the Evidia...

ATOS - SELL | EUR13 The Board rejects a non-binding unsolicited offer for the Evidian business An indicative offer for Evidian for EUR4.2bn from Onepoint and ICG Such an offer does not reflect Evidian’s long-term value potential in our view We reiterate our Sell rating

Gregory Ramirez
  • Gregory Ramirez

ALTEN: R&D is the lifeblood of industries | CONVICTION BUY vs. BUY | E...

ALTEN - CONVICTION BUY vs. BUY | EUR159 VS. EUR178 (+45%) R&D is the lifeblood of industries We upgrade our rating to Conviction Buy from Buy. Alten continues to perform in a supportive industry environment. We also like the clear strategy and believe in the benefits of the offshoring drive. The Engineering & R&D Services market, where Alten is the No. 2, continues to see structural changes pushing industrial groups to accelerate innovation through digitisation. At the same time, prices keep in...

Paul de Froment ... (+2)
  • Paul de Froment
  • Xavier Regnard

Energy transition & Sustainability Green hydrogen finally ready for ta...

The green hydrogen market is moving from a proof-of-concept stage to commercial implementation, accompanied by strong growth in equipment sales. According to BloombergNEF (BNEF), electrolyser sales are projected to at least quadruple in 2022, from c.460 MW in 2021 to 1.8-2.5 GW in 2022, depending on the scenario HydrogenPro initiation of coverage Buy – Tprice NOK50/share Ceres Power Still one of our favourite stocks in the sector ITM Power Struggling to deliver on time McPhy Heading ...

Gregory Ramirez
  • Gregory Ramirez

LECTRA BUY | EUR45 Good resistance Chinese lockdowns; strong orde...

º Q2 results were slightly below expectations, but remained decent despite lockdowns in China New system orders hold up well thanks to automotive Company guidance for 2022 has been tightened toward its mid-point

Thibault Morel
  • Thibault Morel

HMS NETWORKS: HMS Networks 2Q22 results above expectations | CONVICTIO...

HMS NETWORKS - CONVICTION BUY | SEK500 HMS Networks 2Q22 results above expectations 2Q22 sales and new orders above expectations Positive surprise on 2Q22 profitability

Cedric Rossi
  • Cedric Rossi

HUGO BOSS: Successful execution and healthy geo mix lead to raised FY2...

HUGO BOSS - NEUTRAL | EUR68 vs. EUR64 Successful execution and healthy geo mix lead to raised FY22 guidance Strong sales and EBIT beat in Q2 driven by execution… … and low exposure to China’s lockdowns FY22 sales and EBIT guidance revised upwards and we increase our FY22-23 estimates by 7%

Clement Genelot
  • Clement Genelot

ROCHE BOBOIS: Q4 topping expectations with good H1 2022 prospects

ROCHE BOBOIS: Q4 topping expectations with good H1 2022 prospects

Victor Floc’h
  • Victor Floc’h

ONCODESIGN (CORPORATE, TP EUR15) | R&D collaboration signed with TiumB...

ONCODESIGN (CORPORATE, TP EUR15) | R&D collaboration signed with TiumBio in fibrosis

ResearchPool Subscriptions

Get the most out of your insights

Get in touch